Anders Wesslau Mba

Anders Wesslau MBA, BSc is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as a Member of the Board of Directors for The Swedish Association of the Pharmaceutical Industry, LIF since May 2023. Wesslau has held the position of General Manager and Managing Director for Sweden and Iceland at Merck Group since August 2019. Previous roles include Senior Director of Global Strategic Marketing for Neurology and Immunology at EMD Serono, Inc. and various leadership positions in global strategic marketing at Merck Serono, focusing on neurodegenerative and rheumatological diseases. Earlier in the career, Wesslau worked as a Product Specialist for CNS, Urology, and Cardiovascular at Sanofi-Synthelabo. Wesslau holds an MBA from the University of Gothenburg and a Bachelor of Science in Information Technology from Örebro University.